Cumberland Pharmaceuticals Inc
NASDAQ:CPIX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cumberland Pharmaceuticals Inc
NASDAQ:CPIX
|
US |
Intrinsic Value
The intrinsic value of Cumberland Pharmaceuticals Inc (CPIX) under the Base Case is 3.62 USD per share.
Compared with the current market price of 7.54 USD, the stock appears
Overvalued by 52% .
The intrinsic value is calculated using the DCF method. Operating margin recovers from -6.3% last year to 2.7% by 2033. If operating margin stayed at its five-year average of -14%, the estimate would be about $2.13. The value of the years after 2033 is tied to revenue, so margins count only until then.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Cumberland Pharmaceuticals Does
Cumberland Pharmaceuticals is a specialty drug company that develops, acquires, and sells branded prescription medicines, mostly for hospital and other acute-care settings. Its products are used by doctors, nurses, and pharmacists to treat specific conditions where reliable, ready-to-use medicines matter more than broad consumer distribution.
- Headquarters
- United States of America US
- Employees
- 93
- IPO date
- Aug 11, 2009
Revenue & Expenses Breakdown
Cumberland Pharmaceuticals Inc
Earnings Waterfall
Cumberland Pharmaceuticals Inc
The intrinsic value for Cumberland Pharmaceuticals Inc (CPIX) under the Base Case is 3.62 USD.
Compared with the current market price of 7.54 USD, the stock appears Overvalued by 52% .